CTMX
CytomX TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CTMX vs peer average
61/100
CTMX vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GYRE is the first available peer comparator.
Same-sector, similar-market-cap biotech comparator; useful for small-cap development-stage context but not a direct oncology or mechanistic peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CTMX
CytomX Therapeutics
GYRE
Gyre Therapeutics
Grade
C
C
Momentum
26
61
Value
41
43
Sentiment
65
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GYRE
CTMX / GYRE
Grade Position
In line
CTMX vs. peer average (C vs. D)
61/100
Momentum
26
GYREValue
41
GYRESentiment
65
CTMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CTMX
GYRE is the first peer returned for this comparison set.